Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001346585 | SCV001540805 | uncertain significance | Renal carnitine transport defect | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine with phenylalanine at codon 285 of the SLC22A5 protein (p.Ile285Phe). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and phenylalanine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SLC22A5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Giacomini Lab, |
RCV001346585 | SCV002576708 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | criteria provided, single submitter | research | |
Natera, |
RCV002226542 | SCV002078323 | uncertain significance | Decreased circulating carnitine concentration | 2021-01-07 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001346585 | SCV002107446 | uncertain significance | Renal carnitine transport defect | 2021-01-07 | no assertion criteria provided | clinical testing |